Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONCOMEO pilot study of Ruta graveolens 9 CH or Phenacetinum 4 CH in refractory solid tumors
2009-015722-11Phase 2Active
- Sponsor
- Boiron
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Ruta graveolens and Phenacetin in Nonhematologic neoplasms, sponsored by Boiron. Primary endpoint: Tumor response. Started Jul 2010; status: active.
02
Drugs
Ruta graveolensPhenacetin
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on 2009-015722-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015722-11.